Beijing Labtech Instruments Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Beijing Labtech Instruments has a total shareholder equity of CN¥809.5M and total debt of CN¥1.0M, which brings its debt-to-equity ratio to 0.1%. Its total assets and total liabilities are CN¥915.3M and CN¥105.9M respectively. Beijing Labtech Instruments's EBIT is CN¥38.9M making its interest coverage ratio -7.5. It has cash and short-term investments of CN¥467.8M.
Belangrijke informatie
0.1%
Verhouding schuld/eigen vermogen
CN¥1.03m
Schuld
| Rente dekkingsratio | -7.5x |
| Contant | CN¥467.82m |
| Aandelen | CN¥809.45m |
| Totaal verplichtingen | CN¥105.89m |
| Totaal activa | CN¥915.34m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Why Investors Shouldn't Be Surprised By Beijing Labtech Instruments Co., Ltd.'s (SHSE:688056) 41% Share Price Surge
Oct 09
Beijing Labtech Instruments' (SHSE:688056) Soft Earnings Are Actually Better Than They Appear
May 02Beijing Labtech Instruments Co., Ltd. (SHSE:688056) Looks Just Right With A 29% Price Jump
Mar 08Analyse van de financiële positie
Kortlopende schulden: 688056's short term assets (CN¥714.3M) exceed its short term liabilities (CN¥101.1M).
Langlopende schulden: 688056's short term assets (CN¥714.3M) exceed its long term liabilities (CN¥4.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 688056 has more cash than its total debt.
Schuld verminderen: 688056's debt to equity ratio has reduced from 1.8% to 0.1% over the past 5 years.
Schuldendekking: 688056's debt is well covered by operating cash flow (2312.5%).
Rentedekking: 688056 earns more interest than it pays, so coverage of interest payments is not a concern.